Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05642897Not ApplicableRecruiting

Mind Programme for Women With Breast Cancer

Role: collaborator

NCT04019808Completed

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Role: collaborator

NCT03957031Completed

Gastric Cancer Risk Factors Associated With EU and CELAC Populations

Role: collaborator

NCT04015466Completed

Advanced GC Multi-omic Characterization in EU and CELAC Populations

Role: collaborator

NCT05344937Unknown

Validation Study of Uromonitor in High Risk Microhematuria Patients

Role: collaborator

NCT05046769Unknown

COVID-19: A Scope Research on Epidemiology and Clinical Course

Role: collaborator

All 6 trials loaded